Showing results (11-20 of 174) with videos related to
Sort By:
Pageof 18
Diagnostic Microbiology and Infectious Disease|May 1, 1992
In vitro activity of lomefloxacin and other antimicrobials against bacterial enteritis pathogensD Felmingham, M J RobbinsDiagnostic Microbiology and Infectious Disease|August 1, 1996
Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogensR N Grüneberg, D FelminghamInternational Journal of Antimicrobial Agents|November 18, 2005
Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003)G C Schito, D FelminghamThe Journal of Antimicrobial Chemotherapy|February 8, 2000
The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infectionsD Felmingham, R N GrünebergDrugs Under Experimental and Clinical Research|January 1, 1985
The comparative activity of twelve 4-quinolone antimicrobials and sulphadiazine against Neisseria meningitidisD Felmingham, R A WallThe Journal of Infection|July 6, 2005
In vitro activity of telithromycin against Gram-negative bacterial pathogensD Felmingham, D J FarrellThe Journal of Antimicrobial Chemotherapy|September 22, 2001
Activity of the ketolide antibacterial telithromycin against typical community-acquired respiratory pathogensD Felmingham, G Zhanel, D HobanDrugs Under Experimental and Clinical Research|January 1, 1988
In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogensK Jones, D Felmingham, G RidgwaySingapore Medical Journal|February 1, 1990
In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteriaH Hassan, M D O'Hare, D FelminghamClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 7, 2004
Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studiesD E Low, S Brown, D FelminghamPageof 18